Molecular Pharmacology Stock Shares Owned By Insiders
| MLPH Stock | USD 0.0001 0.00 0.00% |
Molecular Pharmacology fundamentals help investors to digest information that contributes to Molecular Pharmacology's financial success or failures. It also enables traders to predict the movement of Molecular Pink Sheet. The fundamental analysis module provides a way to measure Molecular Pharmacology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Molecular Pharmacology pink sheet.
Molecular |
Molecular Pharmacology Company Shares Owned By Insiders Analysis
Molecular Pharmacology's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 0.0% of Molecular Pharmacology are shares owned by insiders. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 100.0% higher than that of the company.
Molecular Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molecular Pharmacology's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Molecular Pharmacology could also be used in its relative valuation, which is a method of valuing Molecular Pharmacology by comparing valuation metrics of similar companies.Molecular Pharmacology is currently under evaluation in shares owned by insiders category among its peers.
Molecular Fundamentals
| Return On Asset | -5.69 | |||
| Current Valuation | 221.59 K | |||
| Shares Outstanding | 111.55 M | |||
| Price To Earning | (0.80) X | |||
| EBITDA | (98.11 K) | |||
| Net Income | (116.93 K) | |||
| Cash And Equivalents | 1.52 K | |||
| Total Debt | 175.33 K | |||
| Current Ratio | 0.28 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (105.41 K) | |||
| Beta | 42.97 | |||
| Market Capitalization | 26.77 K | |||
| Total Asset | 8.97 K | |||
| Working Capital | (2.1 M) | |||
| Current Asset | 9 K | |||
| Current Liabilities | 2.11 M | |||
| Net Asset | 8.97 K |
About Molecular Pharmacology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Molecular Pharmacology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molecular Pharmacology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molecular Pharmacology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Molecular Pink Sheet
Molecular Pharmacology financial ratios help investors to determine whether Molecular Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Molecular with respect to the benefits of owning Molecular Pharmacology security.